TY - JOUR T1 - Cyclic GMP and Phosphodiesterase 5 Inhibitor Therapies: What's on the Horizon? JF - Molecular Pharmacology JO - Mol Pharmacol SP - 11 LP - 13 DO - 10.1124/mol.104.001388 VL - 66 IS - 1 AU - Thomas M. Lincoln Y1 - 2004/07/01 UR - http://molpharm.aspetjournals.org/content/66/1/11.abstract N2 - ER -